MDPI and ACS Style
Ong, H.W.; Yang, X.; Smith, J.L.; Taft-Benz, S.; Howell, S.; Dickmander, R.J.; Havener, T.M.; Sanders, M.K.; Brown, J.W.; Couñago, R.M.;
et al. Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2. Molecules 2024, 29, 4158.
https://doi.org/10.3390/molecules29174158
AMA Style
Ong HW, Yang X, Smith JL, Taft-Benz S, Howell S, Dickmander RJ, Havener TM, Sanders MK, Brown JW, Couñago RM,
et al. Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2. Molecules. 2024; 29(17):4158.
https://doi.org/10.3390/molecules29174158
Chicago/Turabian Style
Ong, Han Wee, Xuan Yang, Jeffery L. Smith, Sharon Taft-Benz, Stefanie Howell, Rebekah J. Dickmander, Tammy M. Havener, Marcia K. Sanders, Jason W. Brown, Rafael M. Couñago,
and et al. 2024. "Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2" Molecules 29, no. 17: 4158.
https://doi.org/10.3390/molecules29174158